Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (29)
  • MAO
    (24)
  • Monoamine Oxidase
    (23)
  • Autophagy
    (12)
  • Cholinesterase (ChE)
    (11)
  • CDK
    (9)
  • Proteasome
    (8)
  • Antibacterial
    (7)
  • Histone Demethylase
    (6)
  • Others
    (260)
Filter
Search Result
Results for "

reversible

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    615
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Peptide Products
    23
    TargetMol | Peptide_Products
  • Dye Reagents
    11
    TargetMol | Dye_Reagents
  • PROTAC Products
    6
    TargetMol | PROTAC
  • Natural Products
    39
    TargetMol | Natural_Products
  • Reagent Kits
    1
    TargetMol | Reagent_Kits
  • Recombinant Protein
    44
    TargetMol | Recombinant_Protein
  • Isotope Products
    14
    TargetMol | Isotope_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    8
    TargetMol | Inhibitors_Agonists
SP600125
Pyrazolanthrone, Nsc75890, JNK Inhibitor II, 1PMV
T3109129-56-6
SP600125 (JNK Inhibitor II) is a JNK inhibitor that inhibits JNK1, JNK2, and JNK3 (IC50=40 40 90 nM) with oral potency, reversibility, and ATP-competitive properties. SP600125 inhibits autophagy and induces apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
pCPA methyl ester hydrochloride
4-Chloro-DL-phenylalanine methyl ester hydrochloride
T4114314173-40-1
pCPA methyl ester hydrochloride (4-Chloro-DL-phenylalanine methyl ester hydrochloride) is an inhibitor of tryptophan hydroxylase inhibitor and 5-HT synthesis. pCPA methyl ester hydrochloride is permeable across the blood-brain barrier and reduces 5-HT central availability.
  • Inquiry Price
Size
QTY
LDN-27219
T11831312946-37-5
LDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.
  • Inquiry Price
Size
QTY
Bortezomib
Radiciol, NSC 681239, MG 341, LDP 341, DPBA, Brotezamide
T2399179324-69-7
Bortezomib (LDP 341) is a 20S proteasome inhibitor (Ki=0.6 nM) that is reversible and selective. Bortezomib has antitumor activity and inhibits NF-κB, which can disrupt the cell cycle and induce apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Clozic
Clobuzarit, ICI 55897
T1083922494-47-9In house
Clozic (ICI 55897) exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
TVB-3664
T171812097262-58-1
TVB-3664 is an orally active, selective, reversible, and highly bioavailable fatty acid synthase inhibitor (FASN) with an IC50 for palmitate synthesis of 18 nM in human and 12 nM in mouse.Significantly inhibits microtubule protein palmitoylation and mRNA expression.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
PND-1186
VS-4718, SR-2516, PND1186, PND 1186
T19501061353-68-1
PND-1186 (VS-4718) is a specific and reversible FAK inhibitor with an IC50 of 1.5 nM.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
MG-132
Z-LLL-al, Z-Leu-Leu-Leu-CHO
T2154133407-82-6
MG-132 (Z-Leu-Leu-Leu-al) is a 26S proteasome inhibitor (IC50=100 nM) that is cell-permeable and reversible. MG-132 acts as an autophagy activator and also induces apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Trichostatin A
TSA
T627058880-19-6
Trichostatin A (TSA), a natural derivative of diene isohydroxamic acids, is a specific and reversible histone deacetylase inhibitor (IC50=1.8 nM) that induces hyperacetylation of core histones to regulate chromatin structure.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Leupeptin Hemisulfate
T6564103476-89-7
Leupeptin hemisulfate is a protease inhibitor with cell membrane-permeable, reversible, competitive, and oral activities. Leupeptin hemisulfate inhibits the activity of Cathepsin B, Cathepsin H, and Cathepsin L, and blocks fusion of amphipathic lysosomes. Leupeptin hemisulfate also has anti-inflammatory activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Bafilomycin A1
Baf A1
T674088899-55-2
Bafilomycin A1 belongs to the macrolide class of antibiotics and is a V-ATPase inhibitor (IC50=0.44 nM) that is specific and reversible. Bafilomycin A1 is an inhibitor of the late phase of autophagy, blocking the fusion of autophagosomes with lysosomes. Bafilomycin A1 also induces apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Ulixertinib
BVD-523, VRT752271
T7005869886-67-9
Ulixertinib (VRT752271) (BVD-523, VRT752271) is an effective and reversible ERK1 ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Iptacopan hydrochloride
LNP023 hydrochloride, Iptacopan HCl
T91891646321-63-2In house
Iptacopan hydrochloride (LNP023 hydrochloride) is an orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 of 10 nM. Iptacopan hydrochloride shows direct, reversible, and high-affinity binding to human factor B with a KD of 7.9 nM.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
GSK3685032
T95732170137-61-6
GSK3685032 is a non-covalent and selective DNMT1 inhibitor(IC50 = 36 nM). The inhibitory effect is time-independent and reversible. GSK3685032 induces loss of DNA methylation and transcriptional activation and inhibits cancer cell growth.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
GSK484 hydrochloride
GTPL8577, AOB6992
TQ00671652591-81-5
GSK484 hydrochloride (GTPL8577) is a reversible peptidyl-arginine deiminase 4 (PAD4) inhibitor. It binds to PAD4 with high affinity, with IC50 of 250 and 50 nM in the presence and absence of 2 mM calcium, respectively. GSK484 promotes the radiosensitivity of colorectal cancer (CRC) and inhibits NET formation in vitro and in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
p-Ethynylphenylalanine
4-Ethynyl-L-phenylalanine
T10142278605-15-5In house
p-Ethynylphenylalanine (4-Ethynyl-L-phenylalanine), a selective, effective, and reversible tryptophan hydroxylase (TPH) inhibitor, exhibits competitive inhibition with a Ki of 32.6 μM.
  • Inquiry Price
8-10weeks
Size
QTY
A-69412
N-1-(Fur-3-ylethyl)-N-hydroxyurea
T10208123606-23-5In house
A-69412 (N-1-(Fur-3-ylethyl)-N-hydroxyurea) is a reversible, specific inhibitor of the hydrophilic 5-lipoxygenase. It has the potential to treat ulcerative colitis and asthma, and possibly other inflammatory and allergic conditions.
  • Inquiry Price
6-8 weeks
Size
QTY
Abeprazan hydrochloride
DWP14012 hydrochloride, Fexuprazan hydrochloride
T102211902954-87-3In house
Abeprazan hydrochloride (Fexuprazan hydrochloride) is an effective reversible potassium-competitive acid blocker with oral activity, inhibiting H+, K+ -atPase by competitive binding to potassium ions without acid activation. Abeprazan hydrochloride is a proton pump inhibitor (PPI) that acts by reducing gastric acid production and is used to treat gastric acid-related disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
DZ2002
T1113433231-14-0In house
DZ2002, an orally active, reversible, and low-cytotoxic type III SAHH inhibitor (Ki=17.9 nM), exhibits significant immunosuppressive activity. It effectively prevents experimental dermal fibrosis by reversing the profibrotic phenotype in multiple cell types, making it useful for studying autoimmune diseases like lupus syndrome and systemic sclerosis.
  • Inquiry Price
6-8 weeks
Size
QTY
EACC
T11142864941-31-1In house
EACC, a reversible autophagy inhibitor, selectively impedes Stx17, an autophagosome-specific SNARE, from translocating, hence obstructing the fusion between autophagosomes and lysosomes. This compound effectively halts autophagic flux.
  • Inquiry Price
6-8 weeks
Size
QTY
Elinogrel
PRT060128
T11177936500-94-6In house
Elinogrel (PRT060128) is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.
  • Inquiry Price
6-8 weeks
Size
QTY
Elubrixin
SB-656933
T11179688763-64-6In house
Elubrixin (SB-656933) inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin can be used for inflammatory diseases such as inflammatory bowel disease and airway inflammation. Elubrixin is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.
  • Inquiry Price
6-8 weeks
Size
QTY
GSK3368715
EPZ019997
T115001629013-22-4In house
GSK3368715 is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50s: 3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). It has strong anti-cancer activity.
  • Inquiry Price
3-6 months
Size
QTY
MLS000544460
T12080352336-36-8In house
MLS000544460 is a highly selective and reversible Eya2 phosphatase inhibitor (Kd: 2.0 μM, IC50: 4 μM) that exhibits inhibitory effects on Eya2 phosphatase-mediated cell migration and has anticancer activity.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale